(1)
EVALUATION OF PRESCRIPTION PATTERN AND ASSOCIATED DRUG INTERACTIONS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH COMORBIDITIES AND COMPLICATIONS IN A TEACHING CARE HOSPITAL. Int. Res. J. Pharm. 2016, 7 (5), 43-47.